Comprehensive analysis of blood-based biomarkers for predicting immunotherapy benefits in patients with advanced non-small cell lung cancer

BACKGROUND: This study aimed to investigate the feasibility of using circulating tumor cells (CTCs), peripheral blood cells (PBCs), and circulating cell-free DNA (cfDNA) as biomarkers of immune checkpoint inhibitor treatment response in patients with advanced non-small cell lung cancer (NSCLC). METH...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Cheol-Kyu, Oh, Hyung-Joo, Kim, Min-Seok, Koh, Bo-Gun, Cho, Hyun-Ju, Kim, Young-Chul, Yang, Hyung-Jeong, Lee, Ji-Young, Chun, Sung-Min, Oh, In-Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182702/
https://www.ncbi.nlm.nih.gov/pubmed/34164263
http://dx.doi.org/10.21037/tlcr-21-100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182702/
https://www.ncbi.nlm.nih.gov/pubmed/34164263
http://dx.doi.org/10.21037/tlcr-21-100

Ejemplares similares